MELISSA ENTRUP: Open Payments
NPI 1053864249 · SADDLE RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 76 payments from 13 companies in 2025. Trend: 2023 $2,035 · 2024 $1,546 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 20 | $431 |
| ARS Pharmaceuticals Operations, Inc. | 17 | $225 |
| Novartis Pharmaceuticals Corporation | 8 | $177 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| LEO Pharma Inc. | 5 | $88 |
| Lilly USA, LLC | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Galderma Laboratories, L.P. | 2 | $62 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Incyte Corporation | 2 | $38 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, XOLAIR, Rhapsido, AIRSUPRA, NEMLUVIO, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
